C4 Therapeutics prices $182 million IPO
LONDON: RTW Venture Fund Limited notes the announcement by its portfolio company C4 Therapeutics on 01 October 2020 of its pricing of a $182.4 million initial public offering (IPO) and admission to trade on Nasdaq Global Market under the ticker “CCCC”. C4T is a USābased biotech company pioneering a new class of small molecule drugs…